Belal Omar Al-Najjar

11PUBLICATIONS
26CO-AUTHORS
Biomolecular modelling and designMolecular targetsChemical and thermal processes in energy and combustionCancer therapy (excl. chemotherapy and radiation therapy)F-block chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 09, 2026
QSAR, molecular dynamics, and biological evaluation of novel myeloperoxidase inhibitors via ligand-based pharmacophore modeling as potential anticancer agents.

|Jul 11, 2026
Target deconvolution of a selective HepG2 cytotoxic hit identifies GSTP1 and TRAP1 as candidate molecular targets.

|Feb 19, 2026
Discovery of hydroxytriazole as a potential glyoxalase-I inhibitor utilizing computer-aided drug design techniques.

MohammedBashar Al-Qazzan, Qosay Al-Balas, Belal Alnajjar

|Aug 06, 2025
Vitamin C as a Cardioprotective Agent Against Doxorubicin-Induced Cardiotoxicity.

Hamdi Nsairat, Zainab Lafi, Bassam M Abualsoud

|Apr 22, 2025
Novel N-Substituted Isatin-Oxoindolin-1H-Benzo[D] Imidazole Fumarate as a New Class of JNK3 Inhibitor: Design, Synthesis, Molecular Modeling and its Biological Activity.

Mohammed M Al-Mahadeen, Areej M Jaber, Belal O Al-Najjar

|Feb 24, 2025
How Advanced are Self-Assembled Nanomaterials for Targeted Drug Delivery? A Comprehensive Review of the Literature.

Hamdi Nsairat, Zainab Lafi, Belal O Al-Najjar

Pageof 2

Frequent Collaborators

2 joint publications

Fadi G Saqallah

2 joint publications

Mohammed M Al-Mahadeen

2 joint publications

Areej M Jaber

2 joint publications

Hamdi Nsairat